|  Help  |  About  |  Contact Us

Publication : Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice.

First Author  Stroobants S Year  2017
Journal  Exp Neurol Volume  291
Pages  106-119 PubMed ID  28189729
Mgi Jnum  J:262131 Mgi Id  MGI:6152900
Doi  10.1016/j.expneurol.2017.02.009 Citation  Stroobants S, et al. (2017) Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice. Exp Neurol 291:106-119
abstractText  Slc17a5(-/-) mice represent an animal model for the infantile form of sialic acid storage disease (SASD). We analyzed genetic and histological time-course expression of myelin and oligodendrocyte (OL) lineage markers in different parts of the CNS, and related this to postnatal neurobehavioral development in these mice. Sialin-deficient mice display a distinct spatiotemporal pattern of sialic acid storage, CNS hypomyelination and leukoencephalopathy. Whereas few genes are differentially expressed in the perinatal stage (p0), microarray analysis revealed increased differential gene expression in later postnatal stages (p10-p18). This included progressive upregulation of neuroinflammatory genes, as well as continuous down-regulation of genes that encode myelin constituents and typical OL lineage markers. Age-related histopathological analysis indicates that initial myelination occurs normally in hindbrain regions, but progression to more frontal areas is affected in Slc17a5(-/-) mice. This course of progressive leukoencephalopathy and CNS hypomyelination delays neurobehavioral development in sialin-deficient mice. Slc17a5(-/-) mice successfully achieve early neurobehavioral milestones, but exhibit progressive delay of later-stage sensory and motor milestones. The present findings may contribute to further understanding of the processes of CNS myelination as well as help to develop therapeutic strategies for SASD and other myelination disorders.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression